The all-day meeting, which will provide the U.S. Food and Drug Administration with the perspective of outside experts, is the last step before the agency decides whether to authorize the single-dose vaccine.
source https://www.wsj.com/articles/johnson-and-johnson-covid-19-vaccine-fda-expert-panel-recommendation-11614294002?mod=pls_whats_news_us_business_f
No comments:
Post a Comment